Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ninian N Lang

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 28, 2022
The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomesJennifer S Lees, Benjamin M P Elyan, Sandra M Herrmann, et al.
Heart (British Cardiac Society)|September 20, 2018
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitorsStephen J H Dobbin, Alan C Cameron, Mark C Petrie, et al.
JACC. Cardiooncology|May 2, 2022
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: <i>JACC: CardioOncology</i> State-of-the-Art ReviewClaire Glen, Yun Yi Tan, Ashita Waterston, et al.
JACC. Cardiooncology|November 16, 2023
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk ScoresClaire Glen, Sarah Adam, Kirsty McDowell, et al.
Heart and Vessels|March 12, 2011
Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limbNicholas L M Cruden, Ninian N Lang, Thomas J MacGillivray, et al.
BMJ Open|August 31, 2021
Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in ScotlandMichael McGettrick, Alexander MacLellan, Paul McCaughey, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Vascular B1 kinin receptors in patients with congestive heart failureNinian N Lang, Nicholas L Cruden, George H Tse, et al.
JACC. Cardiooncology|May 22, 2024
Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor TrialsStephen Rankin, Benjamin Elyan, Robert Jones, et al.
Journal of the American College of Cardiology|May 3, 2008
Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humansIngibjörg J Gudmundsdóttir, Ninian N Lang, Nicholas A Boon, et al.
Biochemical Pharmacology|September 16, 2008
The vascular effects of rotigaptide in vivo in manNinian N Lang, Rachel C Myles, Francis L Burton, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 28, 2022
The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomesJennifer S Lees, Benjamin M P Elyan, Sandra M Herrmann, et al.
Heart (British Cardiac Society)|September 20, 2018
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitorsStephen J H Dobbin, Alan C Cameron, Mark C Petrie, et al.
JACC. Cardiooncology|May 2, 2022
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: <i>JACC: CardioOncology</i> State-of-the-Art ReviewClaire Glen, Yun Yi Tan, Ashita Waterston, et al.
JACC. Cardiooncology|November 16, 2023
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk ScoresClaire Glen, Sarah Adam, Kirsty McDowell, et al.
Heart and Vessels|March 12, 2011
Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limbNicholas L M Cruden, Ninian N Lang, Thomas J MacGillivray, et al.
BMJ Open|August 31, 2021
Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in ScotlandMichael McGettrick, Alexander MacLellan, Paul McCaughey, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Vascular B1 kinin receptors in patients with congestive heart failureNinian N Lang, Nicholas L Cruden, George H Tse, et al.
JACC. Cardiooncology|May 22, 2024
Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor TrialsStephen Rankin, Benjamin Elyan, Robert Jones, et al.
Journal of the American College of Cardiology|May 3, 2008
Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humansIngibjörg J Gudmundsdóttir, Ninian N Lang, Nicholas A Boon, et al.
Biochemical Pharmacology|September 16, 2008
The vascular effects of rotigaptide in vivo in manNinian N Lang, Rachel C Myles, Francis L Burton, et al.
Pageof 9